December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Multifocal ERG in Hydroxychloroquine Patients
JI Markoff
Author Affiliations & Notes
  • JI Markoff
    Dept of Physiology Wills Eye Hospital Philadelphia PA
  • Footnotes
    Commercial Relationships   J.I. Markoff, None. Grant Identification: none
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 1194. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      The Multifocal ERG in Hydroxychloroquine Patients
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      JI Markoff; The Multifocal ERG in Hydroxychloroquine Patients . Invest. Ophthalmol. Vis. Sci. 2002;43(13):1194.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: The purpose of this study was to determine if the multifocal ERG (MERG) might be of diagnostic importance in evaluating asymptomatic and otherwise visually normal patients taking hydroxychloroquine. Method: The MERG was evaluated in 5 (10 eyes) visually asymptomatic patients taking hydroxychlorloquine in doses ranging from 200mg to 400mg daily for 2 to 7 years. All were taking it for rheumatoid arthritis. Ages ranged from 62 to 76 and all were female. Visual acuity, central fields and color plates (Ishihara) remained stable during the course of therapy. Examination of all fundi revealed no pigmentary changes associated with hydroxychloroquine retinopathy. Patients received standard flash ERG (ISCEV protocol) testing and multifocal ERG evaluation using the VERIS Clinic 4.2. Results: All patients had normal flash ERGs. However, each of the twelve eyes studied had markedly reduced or non-recordable MERG. Conclusion: The significance of these findings are that the MERG may detect macular changes prior to any change in visual fields, color vision, fundus or acuity in patients taking hydroxychloroquine. The MERG may prove to have application to other macular diseases before symptoms or physical findings develop and may be useful in early detection.

Keywords: 395 electroretinography: clinical • 554 retina • 355 clinical (human) or epidemiologic studies: risk factor assessment 
© 2002, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2015 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×